| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |